Management

 

Yuling Luo, Ph.D., Founder, President & Chief Executive Officer

Dr. Luo is an entrepreneur with more than 12 years of start-up experience in leadership and innovation. Before ACD, Dr. Luo was a founder of Panomics (previously named Genospectra before its acquisition of Panomics), a life science company that was recently acquired by Affymetrix. At Panomics, Dr. Luo served various roles including Vice President, Functional Genomics and Chief Scientific Officer and he led the development and launch of all of its flagship product lines. Prior to Panomics, Dr. Luo was one of the earliest senior scientists at Exelixis, where he led a team to identify and validate novel therapeutic targets. Dr. Luo has published many research papers in top peer-reviewed journals. His inventions are the subject of over a dozen patents and patent pending applications. Dr. Luo received his doctorate in biochemistry from Case Western Reserve University and conducted post-doctoral research at the University of Pennsylvania.

 

Steve Chen, Ph.D., Founder, Chief Operating Officer

Dr. Chen brings to ACD over 14 years’ experience in technology innovation and management.  Before ACD, Dr. Chen co-founded Genospectra with Dr. Luo, served as its Chief Technology Officer and led the development of its microassay instrumentation systems. Prior to Genospectra, Dr. Chen was an Assistant Professor at University of Maryland, College Park where he conducted research in the field of optical sensors and instrumentation. His research work has resulted in several dozen peer-reviewed journal publications and 6 issued patents. Dr. Chen holds a Ph.D. in Electronic Engineering from University of London.